In-Silico Drug Discovery Market Research 2022 | Industry Growing with Major Key Player Albany Molecular Research Inc.

Comments · 16 Views

The global in-silico drug discovery market size was valued at USD 2.38 billion in 2021 and is projected to reach USD 5.86 billion by 2030 at a CAGR of 10.45% from 2022 to 2030.

In-Silico Drug Discovery Market Scope

A new report titled “Global In-Silico Drug Discovery Market Professional Report 2020-2026” has been added by Straits Research to its repository of research reports. The report analyzes and estimates the In-Silico Drug Discovery market on global, regional, and country levels. The report offers data from previous years and an in-depth analysis based on the revenue. 

The global in-silico drug discovery market size was valued at USD 2.38 billion in 2021 and is projected to reach USD 5.86 billion by 2030 at a CAGR of 10.45% from 2022 to 2030.

While studying the global market for In-Silico Drug Discovery, the report also thoroughly analyzes the driving factors, development trends, restraints, challenges, and lucrative challenges to showcase the current and future market scenario. Straits Research has provided a comprehensive report that consists of the key market strategies based on the latest technologies, applications, and different geographies around the world. The market is expected to show significant growth over the forecast period due to the increasing demand for In-Silico Drug Discovery Industry.

Request Sample Report of Global In-Silico Drug Discovery Market @

Competitive Analysis

Albany Molecular Research Inc. Certara Charles River Laboratories Chemical Computing Group ULC GenScript LakePharma Inc. Sygnature Discovery Abzena Ltd. BioNTech SE Creative Biostructure

These key players have adopted organic and inorganic growth strategies, including new product launches and developments, joint ventures, partnerships, research and development (RD) activities, agreements, contracts, collaborations, and mergers acquisitions (MA) to strengthen their position in the market.

In-Silico Drug Discovery Market Segmentation

Based on Product Software Software-as-a-Service Consultancy-as-a-Service Based on Workflow Discovery Pre-Clinical Tests Clinical Tests Based on Technology Artificial Intelligence Based on Target Therapeutic Area HIV Infectious diseases Metabolic disorders Mental disorders Musculoskeletal disorders Neurological disorders Oncological disorders Respiratory disorders Skin disorders Urogenital disorders Autoimmune disorders Blood disorders Cardiovascular disorders Gastrointestinal and digestive disorders, hormonal disorders, and others. Based on End-User Pharmaceutical and Biopharmaceutical Companies Contract Research Organizations Academic and Research Institutes

This report forecasts revenue growth at the global, regional, and local levels. It analyzes the most recent industry trends from 2020 to 2026 in each of the segments and sub-segments. Some of the major geographies included in the market are given below:

  • North America (U.S., Canada)
  • Europe (U.K., Germany, France, Italy)
  • Asia Pacific (China, India, Japan, Singapore, Malaysia)
  • Latin America (Brazil, Mexico)
  • Middle East Africa

Study Objectives of Global In-Silico Drug Discovery Market:

  • To provide an in-depth analysis of the overall structure of the market along with the forecast of the various segments and sub-segments of the global In-Silico Drug Discovery market.
  • To provide insights about the factors influencing the growth of the market.
  • To study the global In-Silico Drug Discovery market analysis on the basis of porter’s five forces analysis, SWOT, and pestel analysis.
  • To provide historical data and forecast revenue of the market segments and their sub-segments regarding regional distribution, including North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.
  • To provide a detailed country-level analysis of the global industry to determine the current In-Silico Drug Discovery market size and the future prospective.
  • To provide a comprehensive analysis of the market for segments by product type, the technology used, end-users, applications, and region.
  • To strategically profile the leading players functioning in the global In-Silico Drug Discovery market, comprehensively analyze their core competencies, and frame a competitive advantage.
  • To identify and study the key developments such as new product launches, mergers acquisitions (MA), joint ventures, research and development (RD) activities, and strategic alliances in the global In-Silico Drug Discovery market.

Buy Now:

Other features of the report:

  1. Gives a thorough analysis of the key strategies with a focus on the corporate structure, RD methods, localization strategies, production capabilities, sales, and performance in various companies. 
  2. Provides valuable insights into the product portfolio, including product planning, development, and positioning. 
  3. Analyses the role of key market players and their partnerships, mergers, and acquisitions. 

Trending Report:

About Us: is a leading research and intelligence organization, specializing in research, analytics, and advisory services along with providing business insights research reports.

Contact Us:
Address: 825 3rd Avenue, New York, NY, USA, 10022
Tel: +1 6464807505, +44 203 318 2846